Recent Patents in Toll-like Receptor Pathways and Relevance to Cancer

E-ISSN： 2212-3970|4|3|189-195

ISSN： 1574-8928

Source： Recent Patents on Anti-Cancer Drug Discovery, Vol.4, Iss.3, 2009-11, pp. : 189-195

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Immunotherapeutic Impact of Toll-like Receptor Agonists in Breast Cancer

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 15, Iss. 9, 2015-01 ,pp. : 1134-1140

Bentham Science Publishers

Access to resources Recommend Favorite

Toll-like receptor-2 and -4 are associated with hyperlipidemia

Molecular Medicine Reports, Vol. 12, Iss. 6, 2015-01 ,pp. : 8241-8246

Spandidos Publications

Access to resources Recommend Favorite

Triggering of Toll-like receptor 4 on metastatic breast cancer cells promotes αvβ3-mediated adhesion and invasive migration

By Liao Sheng-Jun

Breast Cancer Research and Treatment, Vol. 133, Iss. 3, 2012-06 ,pp. : 853-863

Springer Publishing Company

Access to resources Recommend Favorite

Activation of Toll-like receptor 7 inhibits the proliferation and migration, and induces the apoptosis of pancreatic cancer cells

Molecular Medicine Reports, Vol. 12, Iss. 4, 2015-01 ,pp. : 6079-6085

Spandidos Publications

Access to resources Recommend Favorite

Matrix metalloproteinase-13 is regulated by toll-like receptor-9 in colorectal cancer cells and mediates cellular migration

Oncology Letters, Vol. 2, Iss. 3, 2011-01 ,pp. : 483-488

Spandidos Publications

Access to resources Recommend Favorite